Nik Chetwyn

As senior vice president of operations, Nik provides over 20 years of experience in drug development to Erasca, where he works with talented scientists and staff in the pharmaceutical development and operations (CMC), information technology, operations and facilities, quality assurance, and portfolio and program leadership groups. Nik has worked at several major pharmaceutical companies, including GlaxoSmithKline, Pfizer and Genentech, spanning technical development from discovery to new drug application (NDA) filings (Wellbutrin®, Erivedge® and Cotellic®) and transfer to commercial groups. Upon joining Genentech in 2006, he helped build the small molecule drug development organization and drive the significant expansion of technical and drug manufacturing capabilities. During his Genentech tenure, Nik served on multiple governance committees, was a technical development team leader, and represented Genentech on the board of directors for the Allotrope Foundation. Prior to joining Erasca, he was the co-founder and president of MindScienceConnection, Inc., a strategy and leadership development company that focused on partnering with biopharmaceutical companies to navigate the unique challenges of building and maintaining thriving research cultures while developing the scientific leaders of the future.

Nik earned his M.S. and Ph.D. in pharmaceutical chemistry from the University of Kansas and his B.Sc. in chemical and pharmaceutical sciences from the University of Sunderland.